Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review

Ítems similars

• The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation †
  per: Atienza-Mateo, Belén, et al.
  Publicat: (2020)
• The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
  per: Belén Atienza-Mateo, et al.
  Publicat: (2020-05-01)
• Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
  per: Verónica Pulito-Cueto, et al.
  Publicat: (2022-04-01)
• Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis
  per: Pulito-Cueto, Verónica, et al.
  Publicat: (2020)
• Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients
  per: Pulito-Cueto, Verónica, et al.
  Publicat: (2021)